China NMPA Drug Inspection - Yichang Renfu Pharmaceutical - Inosine tablets
China NMPA drug inspection for Yichang Renfu Pharmaceutical published June 29, 2018. Drug: Inosine tablets. The Ningxia Food and Drug Administration (NMPA) released its Drug Quality Sampling Inspection Information Announcement (
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Yichang Renfu Pharmaceutical published June 29, 2018. Drug: Inosine tablets. The Ningxia Food and Drug Administration (NMPA) released its Drug Quality Sampling Inspection Information Announcement (
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Yichang Renfu PharmaceuticalInspection Date
Unknown Date
Product Type
ID: 08c6e50f-b031-4a0a-927c-b19bbcd87fe7
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox